RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
-17.44%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.12B
AUM Growth
-$643M
(-23%)
Cap. Flow
-$85.3M
Cap. Flow
% of AUM
-4.03%
Top 10 Holdings %
Top 10 Hldgs %
32.59%
Holding
150
New
6
Increased
39
Reduced
39
Closed
16
Top Buys
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$36.4M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$19.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$11.5M |
| 4 |
Neurocrine Biosciences
NBIX
|
$10.3M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$9.78M |
Top Sells
| 1 |
AbbVie
ABBV
|
$30.7M |
| 2 |
Molina Healthcare
MOH
|
$23.6M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$17.3M |
| 4 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$15.1M |
| 5 |
Elanco Animal Health
ELAN
|
$13.1M |
Sector Composition
| 1 | Healthcare | 88.36% |
| 2 | Consumer Staples | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $23.6M | 1.11% |
242,500
-57,500
| -19% | -$5.6M |
|
27
Acadia Healthcare
ACHC
$2.19B
| $23.2M | 1.09% |
900,750
+200,750
| +29% | +$5.16M |
|
28
Align Technology
ALGN
$10.1B
| $22M | 1.04% |
105,000
+37,500
| +56% | +$7.85M |
|
29
Thermo Fisher Scientific
TMO
$186B
| $21.5M | 1.01% |
96,000
| – | – |
|
|
ALLK
30
DELISTED
Allakos
ALLK
| $21.1M | 1% |
404,000
-1,000
| -0.2% | -$52.3K |
|
|
ONCE
31
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $21M | 0.99% |
537,500
| – | – |
|
32
Idexx Laboratories
IDXX
$51.4B
| $20.6M | 0.97% |
110,500
+27,000
| +32% | +$5.02M |
|
33
Baxter International
BAX
$12.5B
| $19.8M | 0.93% |
300,700
+3,700
| +1% | +$244K |
|
34
Incyte
INCY
$16.9B
| $19.7M | 0.93% |
310,000
-42,100
| -12% | -$2.68M |
|
|
35
Ultragenyx Pharmaceutical
RARE
$3.07B
| $18.5M | 0.87% |
425,000
+225,000
| +113% | +$9.78M |
|
|
PRAH
36
DELISTED
PRA Health Sciences, Inc.
PRAH
| $18.4M | 0.87% |
200,000
-88,247
| -31% | -$8.12M |
|
|
RDUS
37
DELISTED
Radius Health, Inc.
RDUS
| $18.1M | 0.86% |
1,100,000
-167,500
| -13% | -$2.76M |
|
38
argenx
ARGX
$45.9B
| $17.1M | 0.81% |
178,000
+13,000
| +8% | +$1.25M |
|
39
Galapagos
GLPG
$2.2B
| $16.3M | 0.77% |
177,500
| – | – |
|
40
West Pharmaceutical
WST
$18B
| $15.7M | 0.74% |
160,000
| – | – |
|
|
NVTA
41
DELISTED
Invitae Corporation
NVTA
| $15.5M | 0.73% |
1,400,000
| – | – |
|
42
Ascendis Pharma
ASND
$12.5B
| $15.3M | 0.72% |
243,500
| – | – |
|
|
ALDR
43
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $15.1M | 0.71% |
1,475,000
-157,500
| -10% | -$1.61M |
|
44
Biogen
BIIB
$20.6B
| $15M | 0.71% |
50,000
| – | – |
|
45
Inogen
INGN
$219M
| $14.5M | 0.69% |
117,000
-9,000
| -7% | -$1.12M |
|
|
OBSV
46
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $14.2M | 0.67% |
1,120,000
| – | – |
|
47
FibroGen
FGEN
$48.9M
| $14.2M | 0.67% |
12,240
| – | – |
|
48
Alnylam Pharmaceuticals
ALNY
$59.2B
| $14.1M | 0.67% |
194,000
-2,500
| -1% | -$182K |
|
49
Theravance Biopharma
TBPH
$703M
| $14.1M | 0.66% |
550,000
| – | – |
|
|
MDCO
50
DELISTED
Medicines Co
MDCO
| $13.9M | 0.66% |
726,900
+36,900
| +5% | +$706K |
|